The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

Oprah's perception of other people's habits isn't the only thing to have changed with the introduction of the weekly ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

In December 2024, the Centers for Medicare & Medicaid Services (CMS) formally approved a new quality measure developed by the ...

Novo Nordisk A/S, GE HealthCare Technologies Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...

I consulted a dietician and a psychologist to find out about this so-called “Ozempic personality.” Related: What Happens When You Take Ozempic for Weight Loss? An Endocrinologist, Aesthetic Medicine ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

Former BBC Radio 4 presenter Dame Jenni Murray has bravely opened up on the lasting impact her mother's obsession with weight ...

The UWMDI is the first of its kind in the Pacific Northwest, integrating state-of-the-art research programs with superb care for patients with diabetes, obesity and their complications ...

On the Jan. 14 episode of The Oprah Podcast, the former talk show host had a conversation with Yale University obesity medicine physician scientist Dr. Ania Jastreboff and clinical psychologist Dr.